<p>Squarepoint Ops LLC 在最近向证券交易委员会（SEC）提交的 13F 文件中表示，在第二季度将其在布鲁克公司（NASDAQ:BRKR - 免费报告）股票中的持股比例减少了 42.7%。该机构投资者在此期间出售了 77,226 股后，持有 103,501 股该医疗研究公司的股票。Squarepoint Ops LLC 在最近一个季度末持有的布鲁克股份约占 0.07%，价值 4,264,000 美元。</p>
<p>其他几家对冲基金和机构投资者最近也调整了对该股票的持有。Nisa Investment Advisors LLC 在第二季度将其在布鲁克的持股比例提高了 377.5%。Nisa Investment Advisors LLC 目前持有 616 股该医疗研究公司的股票，价值 25,000 美元，此前在上个季度又购买了 487 股。亨廷顿国家银行在第二季度将其在布鲁克的持股比例提高了 750.0%。亨廷顿国家银行目前持有 731 股该医疗研究公司的股票，价值 30,000 美元，此前在上个季度又购买了 645 股。Spire Wealth Management 在第二季度获得了布鲁克的新头寸，价值约 32,000 美元。凯通国际资产管理有限公司在第一季度将其在布鲁克的持股比例提高了 1,354.5%。凯通国际资产管理有限公司目前持有 800 股该医疗研究公司的股票，价值 33,000 美元，此前在上个季度又购买了 745 股。最后，Parallel Advisors LLC 在第二季度将其在布鲁克的持股比例提高了 63.0%。Parallel Advisors LLC 目前持有 898 股该医疗研究公司的股票，价值 37,000 美元，此前在上个季度又购买了 347 股。机构投资者持有该公司 79.52% 的股票。</p>
<h2>分析师评级调整</h2>
<p>布鲁克的股票曾受到多份研究报告的关注。TD Cowen 在 11 月 4 日的报告中将布鲁克的目标价格从 40.00 美元上调至 42.00 美元，并给予该股票 &#34;持有&#34; 评级。摩根大通在周一将布鲁克的目标价格从 50.00 美元上调至 55.00 美元，并给予该股票 &#34;增持&#34; 评级。高盛集团在 12 月 9 日的研究报告中开始覆盖布鲁克股票，设定了 &#34;卖出&#34; 评级和 40.00 美元的目标价格。Redburn Partners 在 11 月 20 日的研究报告中设定了布鲁克的目标价格为 60.00 美元。最后，瑞银集团在 11 月 4 日的研究报告中将布鲁克的目标价格从 40.00 美元上调至 43.00 美元，并给予该公司 &#34;中性&#34; 评级。一位股票研究分析师给予该股票 &#34;强烈买入&#34; 评级，八位分析师给予 &#34;买入&#34; 评级，六位分析师给予 &#34;持有&#34; 评级，二位分析师给予 &#34;卖出&#34; 评级。根据 MarketBeat 的数据，布鲁克的共识评级为 &#34;持有&#34;，平均目标价格为 52.86 美元。</p>
<p><strong>阅读我们关于布鲁克的最新股票分析</strong></p>
<h2>布鲁克股票上涨 1.2%</h2>
<p>NASDAQ:BRKR 的股票在周二开盘价为 45.67 美元。布鲁克公司的 52 周低点为 28.53 美元，52 周高点为 64.64 美元。该公司的速动比率为 0.91，流动比率为 1.85，债务股本比率为 0.81。该公司的市值为 69.4 亿美元，市盈率为 -285.44，市盈率/增长比率为 6.64，贝塔值为 1.17。该公司的 50 日移动平均价格为 41.86 美元，200 日移动平均价格为 38.39 美元。</p>
<p>布鲁克（NASDAQ:BRKR - 获取免费报告）最近在 11 月 3 日宣布了其季度财报。该医疗研究公司报告的季度每股收益为 0.45 美元，超出市场共识预期的 0.33 美元，超出幅度为 0.12 美元。该季度的收入为 8.605 亿美元，而分析师预期为 8.474 亿美元。布鲁克的净利润率为 -0.61%，股本回报率为 15.45%。与去年同期相比，布鲁克的收入下降了 0.5%。去年同期，该公司每股收益为 0.60 美元。布鲁克已将其 2025 财年的指导目标设定为 1.850-1.90 每股收益。卖方分析师预计布鲁克公司今年的每股收益将达到 2.69 美元。</p>
<h2>布鲁克分红公告</h2>
<p>该公司最近还宣布了一项季度分红，将于 1 月 2 日（星期五）支付。12 月 8 日的股东将获得每股 0.05 美元的分红。这相当于每年 0.20 美元的分红，收益率为 0.4%。除息日期为 12 月 8 日。布鲁克的派息比率为 -125.00%。</p>
<h2>内部交易活动</h2>
<p>在其他新闻中，董事 John A. Ornell 于 11 月 6 日在一笔交易中出售了 6,233 股该公司的股票。该股票以平均价格 39.00 美元出售，总交易额为 243,087.00 美元。交易后，该董事直接持有该公司 35,212 股股票，价值约 1,373,268 美元。这笔交易代表了其持股比例的 15.04% 的减少。该出售在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站访问。内部人士持有该公司 27.30% 的股票。</p>
<h2>布鲁克公司简介</h2>
<p>（免费报告）</p>
<p>布鲁克公司及其子公司在美国、欧洲、亚太地区及国际上开发、制造和分销科学仪器以及分析和诊断解决方案。该公司通过四个部门运营：布鲁克科学仪器（BSI）生物旋转、BSI CALID、BSI 纳米和布鲁克能源与超导技术。</p>
<h2>特色文章</h2>
<ul>
<li>五只我们认为比布鲁克更好的股票</li>
<li>最佳股息贵族名单：通过贵族指数积累财富</li>
<li>ServiceNow 的 70 亿美元赌注：恐慌还是机会？</li>
<li>什么是股息收割策略，投资者如何从中获利？</li>
<li>戴尔和惠普正在提价——投资者应该注意</li>
<li>房地产投资信托是否应在您的投资组合中占有一席之地？</li>
<li>为什么 DLocal 是 2026 年值得关注的顶级新兴市场金融科技股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元在布鲁克吗？</h2>
<p>在您考虑布鲁克之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而布鲁克并不在名单上。</p>
<p>虽然布鲁克目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

布鲁克

<p>Squarepoint Ops LLC 在第二季度减少了对布鲁克公司的持股，降幅为 42.7%，目前持有 103,501 股，价值 426 万美元。其他机构投资者也调整了他们的持股，有些则增加了持股比例。分析师对布鲁克的评级意见不一，普遍维持 “持有” 评级，平均目标价为 52.86 美元。布鲁克的股票开盘价为 45.67 美元，52 周价格区间为 28.53 美元至 64.64 美元。该公司报告第三季度每股收益为 0.45 美元，超出预期，并宣布季度股息为每股 0.05 美元</p>

<p>Squarepoint Ops LLC reduced its stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 42.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,501 shares of the medical research company's stock after selling 77,226 shares during the period. Squarepoint Ops LLC owned about 0.07% of Bruker worth $4,264,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Squarepoint Ops LLC 在最近向证券交易委员会（SEC）提交的 13F 文件中表示，在第二季度将其在布鲁克公司（NASDAQ:BRKR - 免费报告）股票中的持股比例减少了 42.7%。该机构投资者在此期间出售了 77,226 股后，持有 103,501 股该医疗研究公司的股票。Squarepoint Ops LLC 在最近一个季度末持有的布鲁克股份约占 0.07%，价值 4,264,000 美元。</p>
</div><p>Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Nisa Investment Advisors LLC raised its stake in shares of Bruker by 377.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 616 shares of the medical research company's stock valued at $25,000 after purchasing an additional 487 shares in the last quarter. Huntington National Bank lifted its holdings in Bruker by 750.0% during the 2nd quarter. Huntington National Bank now owns 731 shares of the medical research company's stock worth $30,000 after buying an additional 645 shares during the last quarter. Spire Wealth Management acquired a new position in shares of Bruker in the 2nd quarter worth approximately $32,000. Caitong International Asset Management Co. Ltd increased its holdings in shares of Bruker by 1,354.5% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company's stock valued at $33,000 after acquiring an additional 745 shares during the last quarter. Finally, Parallel Advisors LLC raised its position in shares of Bruker by 63.0% during the 2nd quarter. Parallel Advisors LLC now owns 898 shares of the medical research company's stock valued at $37,000 after acquiring an additional 347 shares in the last quarter. Institutional investors own 79.52% of the company's stock.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者最近也调整了对该股票的持有。Nisa Investment Advisors LLC 在第二季度将其在布鲁克的持股比例提高了 377.5%。Nisa Investment Advisors LLC 目前持有 616 股该医疗研究公司的股票，价值 25,000 美元，此前在上个季度又购买了 487 股。亨廷顿国家银行在第二季度将其在布鲁克的持股比例提高了 750.0%。亨廷顿国家银行目前持有 731 股该医疗研究公司的股票，价值 30,000 美元，此前在上个季度又购买了 645 股。Spire Wealth Management 在第二季度获得了布鲁克的新头寸，价值约 32,000 美元。凯通国际资产管理有限公司在第一季度将其在布鲁克的持股比例提高了 1,354.5%。凯通国际资产管理有限公司目前持有 800 股该医疗研究公司的股票，价值 33,000 美元，此前在上个季度又购买了 745 股。最后，Parallel Advisors LLC 在第二季度将其在布鲁克的持股比例提高了 63.0%。Parallel Advisors LLC 目前持有 898 股该医疗研究公司的股票，价值 37,000 美元，此前在上个季度又购买了 347 股。机构投资者持有该公司 79.52% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><p>BRKR has been the subject of a number of research reports. TD Cowen lifted their price objective on shares of Bruker from $40.00 to $42.00 and gave the stock a &#34;hold&#34; rating in a report on Tuesday, November 4th. JPMorgan Chase &amp; Co. raised their price target on shares of Bruker from $50.00 to $55.00 and gave the stock an &#34;overweight&#34; rating in a research report on Monday. The Goldman Sachs Group initiated coverage on shares of Bruker in a research report on Tuesday, December 9th. They set a &#34;sell&#34; rating and a $40.00 price objective for the company. Redburn Partners set a $60.00 price objective on shares of Bruker in a research note on Thursday, November 20th. Finally, UBS Group lifted their target price on Bruker from $40.00 to $43.00 and gave the company a &#34;neutral&#34; rating in a research note on Tuesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Bruker has a consensus rating of &#34;Hold&#34; and an average target price of $52.86.</p>
<div class="lb-trans"><p>布鲁克的股票曾受到多份研究报告的关注。TD Cowen 在 11 月 4 日的报告中将布鲁克的目标价格从 40.00 美元上调至 42.00 美元，并给予该股票 &#34;持有&#34; 评级。摩根大通在周一将布鲁克的目标价格从 50.00 美元上调至 55.00 美元，并给予该股票 &#34;增持&#34; 评级。高盛集团在 12 月 9 日的研究报告中开始覆盖布鲁克股票，设定了 &#34;卖出&#34; 评级和 40.00 美元的目标价格。Redburn Partners 在 11 月 20 日的研究报告中设定了布鲁克的目标价格为 60.00 美元。最后，瑞银集团在 11 月 4 日的研究报告中将布鲁克的目标价格从 40.00 美元上调至 43.00 美元，并给予该公司 &#34;中性&#34; 评级。一位股票研究分析师给予该股票 &#34;强烈买入&#34; 评级，八位分析师给予 &#34;买入&#34; 评级，六位分析师给予 &#34;持有&#34; 评级，二位分析师给予 &#34;卖出&#34; 评级。根据 MarketBeat 的数据，布鲁克的共识评级为 &#34;持有&#34;，平均目标价格为 52.86 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on Bruker</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于布鲁克的最新股票分析</strong></p>
</div><h2>Bruker Trading Up 1.2%</h2>
<div class="lb-trans"><h2>布鲁克股票上涨 1.2%</h2>
</div><p>Shares of NASDAQ:BRKR opened at $45.67 on Tuesday. Bruker Corporation has a fifty-two week low of $28.53 and a fifty-two week high of $64.64. The company has a quick ratio of 0.91, a current ratio of 1.85 and a debt-to-equity ratio of 0.81. The company has a market cap of $6.94 billion, a PE ratio of -285.44, a P/E/G ratio of 6.64 and a beta of 1.17. The company's 50-day moving average price is $41.86 and its 200 day moving average price is $38.39.</p>
<div class="lb-trans"><p>NASDAQ:BRKR 的股票在周二开盘价为 45.67 美元。布鲁克公司的 52 周低点为 28.53 美元，52 周高点为 64.64 美元。该公司的速动比率为 0.91，流动比率为 1.85，债务股本比率为 0.81。该公司的市值为 69.4 亿美元，市盈率为 -285.44，市盈率/增长比率为 6.64，贝塔值为 1.17。该公司的 50 日移动平均价格为 41.86 美元，200 日移动平均价格为 38.39 美元。</p>
</div><p>Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings results on Monday, November 3rd. The medical research company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.33 by $0.12. The company had revenue of $860.50 million for the quarter, compared to analyst estimates of $847.40 million. Bruker had a negative net margin of 0.61% and a positive return on equity of 15.45%. Bruker's revenue was down .5% compared to the same quarter last year. During the same quarter last year, the business earned $0.60 earnings per share. Bruker has set its FY 2025 guidance at 1.850-1.90 EPS. Sell-side analysts anticipate that Bruker Corporation will post 2.69 earnings per share for the current year.</p>
<div class="lb-trans"><p>布鲁克（NASDAQ:BRKR - 获取免费报告）最近在 11 月 3 日宣布了其季度财报。该医疗研究公司报告的季度每股收益为 0.45 美元，超出市场共识预期的 0.33 美元，超出幅度为 0.12 美元。该季度的收入为 8.605 亿美元，而分析师预期为 8.474 亿美元。布鲁克的净利润率为 -0.61%，股本回报率为 15.45%。与去年同期相比，布鲁克的收入下降了 0.5%。去年同期，该公司每股收益为 0.60 美元。布鲁克已将其 2025 财年的指导目标设定为 1.850-1.90 每股收益。卖方分析师预计布鲁克公司今年的每股收益将达到 2.69 美元。</p>
</div><h2>Bruker Dividend Announcement</h2>
<div class="lb-trans"><h2>布鲁克分红公告</h2>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 8th will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, December 8th. Bruker's payout ratio is -125.00%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 1 月 2 日（星期五）支付。12 月 8 日的股东将获得每股 0.05 美元的分红。这相当于每年 0.20 美元的分红，收益率为 0.4%。除息日期为 12 月 8 日。布鲁克的派息比率为 -125.00%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><p>In other news, Director John A. Ornell sold 6,233 shares of the firm's stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $39.00, for a total transaction of $243,087.00. Following the transaction, the director directly owned 35,212 shares of the company's stock, valued at approximately $1,373,268. This trade represents a 15.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Insiders own 27.30% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，董事 John A. Ornell 于 11 月 6 日在一笔交易中出售了 6,233 股该公司的股票。该股票以平均价格 39.00 美元出售，总交易额为 243,087.00 美元。交易后，该董事直接持有该公司 35,212 股股票，价值约 1,373,268 美元。这笔交易代表了其持股比例的 15.04% 的减少。该出售在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站访问。内部人士持有该公司 27.30% 的股票。</p>
</div><h2>Bruker Company Profile</h2>
<div class="lb-trans"><h2>布鲁克公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy &amp; Supercon Technologies.</p>
<div class="lb-trans"><p>布鲁克公司及其子公司在美国、欧洲、亚太地区及国际上开发、制造和分销科学仪器以及分析和诊断解决方案。该公司通过四个部门运营：布鲁克科学仪器（BSI）生物旋转、BSI CALID、BSI 纳米和布鲁克能源与超导技术。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Bruker</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li>
<li>What is a Dividend Harvesting Strategy and How Can Investors Profit from it?</li>
<li>Dell and HP Are Raising Prices—And Investors Should Take Note</li>
<li>Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?</li>
<li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比布鲁克更好的股票</li>
<li>最佳股息贵族名单：通过贵族指数积累财富</li>
<li>ServiceNow 的 70 亿美元赌注：恐慌还是机会？</li>
<li>什么是股息收割策略，投资者如何从中获利？</li>
<li>戴尔和惠普正在提价——投资者应该注意</li>
<li>房地产投资信托是否应在您的投资组合中占有一席之地？</li>
<li>为什么 DLocal 是 2026 年值得关注的顶级新兴市场金融科技股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=BRKR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bruker Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在布鲁克吗？</h2>
</div><p>Before you consider Bruker, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑布鲁克之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bruker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而布鲁克并不在名单上。</p>
</div><p>While Bruker currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然布鲁克目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Squarepoint Ops LLC 出售了布鲁克公司 $BRKR 的股票